Abstract
Biomarker studies for the diagnosis of myocardial infarction are continuing. Adropin is a biomarker that has been researched and found to have various effects. The purpose of this study was to look at the adropin levels of patients who had a myocardial infarction and angina pectoris. Material and Methods: The control group comprised 30 individuals whose troponin levels did not rise and no coronary lesions were found. In the myocardial infarction group, 30 patients had an elevated ECG, and 30 patients had angina pectoris. They were diagnosed by clinicians and tested for Adropin, Fetuin-A, Selenoprotein-P, MDA, and Copeptin. Results: In the MI group, a significant increase was observed in the adropin level p < 0.01**. While a strong positive correlation existed between Fetuin-A and adropin (r= 0.82, p< 0.001) as well as between selenoprotein-P and adropin (r= 0.64, p< 0.001)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Prevention, Diagnosis and Management of Human Diseases
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
